Nephrospec Switzerland

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

June 30, 2026

Conditions
Chronic Kidney DiseasesHypertension
Interventions
DEVICE

NephrospecTM, low-intensity extracorporal shockwave therapy device

"Patients will receive 6 Li-ESWT treatments with the NephrospecTM device over three consecutive weeks, with a minimal recess of 24 hours between treatments and a maximum of 3 sessions per week.~Three hundred shockwaves will be applied by the PI or co-PI to each one of 8 pre-selected regions of each kidney, under ultrasound control, with the patient in the prone position. No local anaesthesia is needed. Total treatment time of one session is 30 minutes. The participant will remain under supervision for another 30 minutes and will be discharged hereafter."

DEVICE

Sham-Device

The sham device is the NephrospecTM applicator with an internal barrier to prevent shockwaves to pass through to the patient.

Trial Locations (1)

1011

RECRUITING

Department of Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne

All Listed Sponsors
lead

Menno Pruijm

OTHER